These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11158403

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.
    Haynes WG, Hand MF, Johnstone HA, Padfield PL, Webb DJ.
    J Clin Invest; 1994 Oct; 94(4):1359-64. PubMed ID: 7929810
    [Abstract] [Full Text] [Related]

  • 3. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
    Hand MF, Haynes WG, Webb DJ.
    Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085
    [Abstract] [Full Text] [Related]

  • 4. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ, Haynes WG, Hand MF, Webb DJ.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [Abstract] [Full Text] [Related]

  • 5. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
    Ferro CJ, Strachan FE, Shepherd E, Haynes WG, Webb DJ.
    Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
    [Abstract] [Full Text] [Related]

  • 6. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ.
    Circulation; 2004 Mar 09; 109(9):1186-93. PubMed ID: 14981006
    [Abstract] [Full Text] [Related]

  • 7. Venous endothelin receptor function in patients with chronic heart failure.
    Love MP, Haynes WG, Webb DJ, McMurray JJ.
    Clin Sci (Lond); 2000 Jan 09; 98(1):65-70. PubMed ID: 10600660
    [Abstract] [Full Text] [Related]

  • 8. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
    Büssemaker E, Passauer J, Reimann D, Schulze B, Reichel W, Gross P.
    Kidney Int; 2002 Sep 09; 62(3):940-8. PubMed ID: 12164876
    [Abstract] [Full Text] [Related]

  • 9. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients.
    Passauer J, Lässig G, Büssemaker E, Pistrosch F, Gross P.
    Kidney Int; 2004 May 09; 65(5):1782-9. PubMed ID: 15086917
    [Abstract] [Full Text] [Related]

  • 10. Endothelin-induced venoconstriction is unaffected by type 2-diabetes: in vivo effect of histamine on the endothelin action on veins.
    Blöchl-Daum B, Vierhapper H, Eichler HG, Waldhäusl W.
    Arch Int Pharmacodyn Ther; 1992 May 09; 316():90-6. PubMed ID: 1530376
    [Abstract] [Full Text] [Related]

  • 11. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC, McG Thom SA, Regan L, Hughes AD.
    Clin Sci (Lond); 2002 Jun 09; 102(6):661-6. PubMed ID: 12049621
    [Abstract] [Full Text] [Related]

  • 12. Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension.
    Sudano I, Virdis A, Taddei S, Spieker L, Corti R, Noll G, Salvetti A, Luscher TF.
    Hypertension; 2007 Feb 09; 49(2):285-90. PubMed ID: 17178974
    [Abstract] [Full Text] [Related]

  • 13. Regular aerobic exercise reduces endothelin-1-mediated vasoconstrictor tone in overweight and obese adults.
    Dow CA, Stauffer BL, Brunjes DL, Greiner JJ, DeSouza CA.
    Exp Physiol; 2017 Sep 01; 102(9):1133-1142. PubMed ID: 28635124
    [Abstract] [Full Text] [Related]

  • 14. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.
    Lipa JE, Neligan PC, Perreault TM, Baribeau J, Levine RH, Knowlton RJ, Pang CY.
    Am J Physiol; 1999 Feb 01; 276(2):H359-67. PubMed ID: 9950834
    [Abstract] [Full Text] [Related]

  • 15. Role of endothelin in hypertension of experimental chronic renal failure.
    Potter GS, Johnson RJ, Fink GD.
    Hypertension; 1997 Dec 01; 30(6):1578-84. PubMed ID: 9403586
    [Abstract] [Full Text] [Related]

  • 16. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Li L, Watts SW, Banes AK, Galligan JJ, Fink GD, Chen AF.
    Hypertension; 2003 Sep 01; 42(3):316-21. PubMed ID: 12885792
    [Abstract] [Full Text] [Related]

  • 17. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P.
    Scand Cardiovasc J Suppl; 1997 Sep 01; 46():1-40. PubMed ID: 9265559
    [Abstract] [Full Text] [Related]

  • 18. Venoconstriction to endothelin-1 in humans is attenuated by local generation of prostacyclin but not nitric oxide.
    Webb DJ, Haynes WG.
    J Cardiovasc Pharmacol; 1993 Sep 01; 22 Suppl 8():S317-20. PubMed ID: 7509975
    [Abstract] [Full Text] [Related]

  • 19. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
    Abdelmawla AH, Langley RW, Szabadi E, Bradshaw CM.
    Br J Clin Pharmacol; 1997 Jul 01; 44(1):61-8. PubMed ID: 9241098
    [Abstract] [Full Text] [Related]

  • 20. Influence of systemically given placebo, trapidil and isosorbide dinitrate on norepinephrine-evoked hand vein constriction in healthy subjects.
    Sziegoleit W, Dannenberg K, Konschak A, Lautenschläger C, Presek P.
    Arzneimittelforschung; 2007 Jul 01; 57(2):81-6. PubMed ID: 17396617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.